Literature DB >> 23051723

Treatment of fibrostenotic and fistulizing Crohn's disease.

Alain M Schoepfer1, Ekaterina Safroneeva, Stephan R Vavricka, Laurent Peyrin-Biroulet, Christian Mottet.   

Abstract

The majority of Crohn's disease patients will develop a complicated disease course over time which is characterized by the occurrence of stricturing and penetrating disease. Penetrating disease comprises internal fistulas (e.g. enteroenteric) and perianal disease. A complicated disease course may be associated with considerable morbidity and professional and personal disabilities. Treatment options for fibrostenotic Crohn's disease comprise endoscopic balloon dilation, stricturoplasties and surgical resection. Treatment of symptomatic perianal fistulizing disease is based on antibiotics, immunomodulators and anti-TNF drugs. Surgical measures include fistula drainage by means of setons, temporary ileostomy or a proctectomy. The presence of internal fistulas often necessitates surgical measures. A close collaboration between the gastroenterologist and the surgeon is mandatory to solve these interdisciplinary challenges.
Copyright © 2012 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23051723     DOI: 10.1159/000341961

Source DB:  PubMed          Journal:  Digestion        ISSN: 0012-2823            Impact factor:   3.216


  8 in total

Review 1.  Assessment of stricturing Crohn's disease: Current clinical practice and future avenues.

Authors:  Dominik Bettenworth; Tobias M Nowacki; Friederike Cordes; Boris Buerke; Frank Lenze
Journal:  World J Gastroenterol       Date:  2016-01-21       Impact factor: 5.742

Review 2.  Fibrogenesis and fibrosis in inflammatory bowel diseases: Good and bad side of same coin?

Authors:  Mariabeatrice Principi; Floriana Giorgio; Giuseppe Losurdo; Viviana Neve; Antonella Contaldo; Alfredo Di Leo; Enzo Ierardi
Journal:  World J Gastrointest Pathophysiol       Date:  2013-11-15

Review 3.  Medical, Endoscopic and Surgical Management of Stricturing Crohn's Disease: Current Clinical Practice.

Authors:  Fotios S Fousekis; Ioannis V Mitselos; Kostas Tepelenis; George Pappas-Gogos; Konstantinos H Katsanos; Georgios D Lianos; Francesco Frattini; Konstantinos Vlachos; Dimitrios K Christodoulou
Journal:  J Clin Med       Date:  2022-04-23       Impact factor: 4.964

Review 4.  Are faecal markers good indicators of mucosal healing in inflammatory bowel disease?

Authors:  Gudula Jam Boon; Andrew S Day; Chris J Mulder; Richard B Gearry
Journal:  World J Gastroenterol       Date:  2015-10-28       Impact factor: 5.742

5.  Medical therapy of stricturing Crohn's disease: what the gut can learn from other organs - a systematic review.

Authors:  Dominik Bettenworth; Florian Rieder
Journal:  Fibrogenesis Tissue Repair       Date:  2014-03-29

6.  Clinical Factors and Disease Course Related to Diagnostic Delay in Korean Crohn's Disease Patients: Results from the CONNECT Study.

Authors:  Chang Mo Moon; Sung-Ae Jung; Seong-Eun Kim; Hyun Joo Song; Yunho Jung; Byong Duk Ye; Jae Hee Cheon; You Sun Kim; Young-Ho Kim; Joo Sung Kim; Dong Soo Han
Journal:  PLoS One       Date:  2015-12-08       Impact factor: 3.240

Review 7.  Medical Therapy of Fibrostenotic Crohn's Disease.

Authors:  Britta Siegmund
Journal:  Viszeralmedizin       Date:  2015-07-28

8.  Levels of Intestinal Inflammation and Fibrosis in Resection Specimens after Preoperative Anti-Tumor Necrosis Factor Alpha Treatment in Patients with Crohn's Disease: A Comparative Pilot Study.

Authors:  J Torle; P D Dabir; U Korsgaard; J Christiansen; N Qvist; A El-Hussuna
Journal:  Surg Res Pract       Date:  2020-02-21
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.